News
Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...
Conflicts of interest on federal government vaccine panels have declined to “historically low levels” in recent years ...
The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...
A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...
The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said ...
An empty reserve undermines national preparedness for health crises like pandemics and bioterrorism where rapid access to ...
By combining the ETHIC bill and a legislative formulation of a withdrawn USPTO rule, Congress has an opportunity to enact ...
A closer look at the top biotechnology and pharmaceutical companies in the 2025 IndustryWeek 500. The pharmaceutical industry ...
The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...
The industry’s reputation surged during the COVID-19 pandemic, according to PatientView’s annual survey of patient groups, peaking two years ago, when 60% of those surveyed said pharma’s ...
The partnership grants Envirotainer exclusive global rights to offer the innovative Swiss Airtainer as part of its full ...
Envirotainer invests in Swiss Airtainer to drive sustainable innovation in pharmaceutical cold chain
This partnership offers a preview of the future: smarter containers that integrate renewable energy, digital visibility, and lightweight design into one solution.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results